Chandan Healthcare Limited (NSE:CHANDAN)
India · Delayed Price · Currency is INR 228.70
-14.65 (-6.02%)
At close: Jun 1, 2026
Chandan Healthcare Revenue
In the fiscal year ending March 31, 2026, Chandan Healthcare had annual revenue of 2.81B INR with 21.31% growth. Chandan Healthcare had revenue of 774.07M in the quarter ending March 31, 2026, with 21.15% growth.
Revenue
2.81B
Revenue Growth
+21.31%
P/S Ratio
2.02
Revenue / Employee
2.35M
Employees
1,192
Market Cap
5.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.81B | 493.04M | 21.31% |
| Mar 31, 2025 | 2.31B | 546.88M | 30.95% |
| Mar 31, 2024 | 1.77B | 397.91M | 29.07% |
| Mar 31, 2023 | 1.37B | 173.26M | 14.49% |
| Mar 31, 2022 | 1.20B | 324.01M | 37.17% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Thyrocare Technologies | 8.29B |
| One Global Service Provider | 4.99B |
| Star Imaging and Path Lab | 885.27M |
| Modern Diagnostic & Research Centre | 814.48M |
| Invicta Diagnostic | 330.42M |
| Aspira Pathlab & Diagnostics | 249.82M |
| Clinitech Laboratory | 96.79M |
| Dr Lalchandani Labs | 43.80M |